Trials / Unknown
UnknownNCT05106972
Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
A Single Center, Prospective Study of Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Asia Stem Cell Regenerative Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the safety and clinical efficacy of umbilical cord mesenchymal stem cell transplantation for decompensated hepatitis B cirrhosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UC-MSC infusion | UC-MSC infusion by introvenus |
Timeline
- Start date
- 2021-12-01
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
- First posted
- 2021-11-04
- Last updated
- 2021-11-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05106972. Inclusion in this directory is not an endorsement.